I underestand your frustration, specially after previous FDA rounds upuntill last year, but there is one fact, regardless of promises or lies by anyone, including SI;
BIG pharma have deep pockets and they do not care paying 10 folds to partner buy a small cap post-FDA approval, than paying a billion ("a silver change" to them) pre-FDA.
So, maybe for your own sanity conside parking the hope/idea of partnership at this point.
I underestand your frustration, specially after previous FDA...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |